![Michael Tung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tung
Director of Finance/CFO at
VTV THERAPEUTICS INC.
Net worth: 375 188 $ as of 2026-05-30
Profile
Dr. Michael S.
Tung is a Chief Financial Officer & Executive Vice President at vTv Therapeutics, Inc. Dr. Tung was previously employed as a Chief Financial Officer by AdvanCell Isotopes Pty Ltd., a Vice President-Strategy & Investor Relations by FibroGen, Inc., a Senior VP-Strategy & Investor Relations by Aclaris Therapeutics, Inc., a Senior Portfolio Manager & Global Equity Analyst by Turner Investments LP, a Vice President by Macquarie Investment Management Business Trust, an Analyst by Galleon Management LP., an Analyst by Hambrecht & Quist Capital Management LLC, a Junior Analyst by Durus Capital Management LLC, an Anesthesiologist by Beth Israel Deaconess Medical Center, Inc., and a Senior Analyst by Expo Capital Management LLC.
He received his undergraduate degree from George Washington University, an MBA from Tufts University School of Medicine and a doctorate degree from Tufts University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-31 | 11,250 ( 0.29% ) | 375 188 $ | 2026-05-30 |
Michael Tung active positions
| Companies | Position | Start |
|---|---|---|
| VTV THERAPEUTICS INC. | Director of Finance/CFO | 2025-05-18 |
Former positions of Michael Tung
| Companies | Position | End |
|---|---|---|
AdvanCell Isotopes Pty Ltd.
 AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Director of Finance/CFO | 2024-12-31 |
| KYNTRA BIO, INC. | Investor Relations Contact | 2023-06-30 |
| ACLARIS THERAPEUTICS, INC. | Investor Relations Contact | 2020-03-31 |
Nomura Investment Management Business Trust
 Nomura Investment Management Business Trust Investment ManagersFinance MIMBT maintains a flexible strategy designed to conform with various clients’ individual investment objectives. The firm manages separate client-focused equity, debt, and balanced portfolios. They invest in the public equity and debt markets of the US, non-US, and other emerging economies. MIMBT seeks growth-oriented value stocks of small-cap, mid-cap and large-cap companies. The firm selects countries by utilizing a top-down approach and selects stocks using fundamental analysis with a bottom-up approach. | Analyst-Equity | 2010-07-30 |
Galleon Management LP.
 Galleon Management LP. Investment ManagersFinance Provides investment advice | Analyst-Equity | 2006-06-29 |
Training of Michael Tung
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Nomura Investment Management Business Trust
Nomura Investment Management Business Trust Investment ManagersFinance MIMBT maintains a flexible strategy designed to conform with various clients’ individual investment objectives. The firm manages separate client-focused equity, debt, and balanced portfolios. They invest in the public equity and debt markets of the US, non-US, and other emerging economies. MIMBT seeks growth-oriented value stocks of small-cap, mid-cap and large-cap companies. The firm selects countries by utilizing a top-down approach and selects stocks using fundamental analysis with a bottom-up approach. | Finance |
Galleon Management LP.
Galleon Management LP. Investment ManagersFinance Provides investment advice | Finance |
Durus Capital Management LLC
 Durus Capital Management LLC Investment ManagersFinance Durus invests long/short in the small-cap healthcare technology sector. | Finance |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Expo Capital Management LLC
 Expo Capital Management LLC Investment ManagersFinance Expo manages Capital Management manages a healthcare sector long/short equity hedge fund called the Expo Health Sciences Fund. | Finance |
Turner Investments LP
 Turner Investments LP Investment ManagersFinance Turner Investments manages a variety of investment strategies focused on growth, including US domestic, global, international and long/short research-driven equity strategies. The firm also manages and administers the Turner Funds, a family of US mutual funds, and the Turner Funds plc, a family of two UCITS funds administered in Dublin, Ireland. Turner Investments' investment philosophy focuses on the long-term and seeks to achieve consistently superior investment returns. The firm employs a disciplined, systematic investment processes for each of their investment strategies and actively manages client portfolios to balance risk and return. Their investment processes are primarily based on in-depth, bottom-up fundamental research analysis, complemented by quantitative and technical analysis. | Finance |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
AdvanCell Isotopes Pty Ltd.
AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Commercial Services |
- Stock Market
- Insiders
- Michael Tung
Choose MarketScreener 
